This study indicated that high-dose RCEG (≥0.08 g/kg/d) can improve HbA1c, FPG and total cholesterol and is safe for patients with type 2 diabetes with or without OHA/insulin therapy. Here, INS is linked to type 2 diabetes mellitus.